Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...
A new way to grow T cells in the lab enables them to live longer and better destroy cancer cells in a mouse model of melanoma ...
Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.
Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...
T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new study. Researchers at Karolinska Institutet have investigated how immune cells ...
New types of T cells seem to pop up in the scientific literature with increasing frequency. Just this June, for instance, University of Melbourne immunologist Angela Pizzolla and her colleagues ...
Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...
T cells were stimulated with anti-CD3/CD28 Dynabeads (Thermo Fisher Scientific) at a bead to T cell ratio of 1:1 and cultured in X-Vivo 15 medium (Lonza), supplemented with 5% (v/v) heat-inactivated ...